Two new sesquiterpenoids peltopterins A and B (compounds 1 and 2) and fifty-two known compounds were isolated from the methanol extract of P. pterocarpum and their chemical structures were established through spectroscopic and mass spectrometric analyses. The isolates 40, 43, 44, 47, 48, 51 and 52 exhibited potential inhibitory effects of superoxide anion generation or elastase release.
Introduction
Peltophorum pterocarpum (DC.) Backer ex K. Heyne (Fabaceae) is a deciduous tree originated from the tropical regions, ex. Sri Lanka, the Andamans, the Malay Peninsula and North Australia [1] . Traditionally, its flowers are used for slowing intestinal diseases and childbirth pain, treating muscle sprains, bruises, swelling and pain [2] . Roots and barks are also used to cure abdominal colic, joint and back pain, and ascites [3] . Reports on Peltophorum species have described antibacterial [4, 5] , antifungal [6, 7] , antivirus [8, 9] , antioxidant [10] , antitumor [10, 11] , deworming [12, 13] , hypoglycemic [2, 14] , cardiotonic [15] , hepatoprotective [16] and leukoagglutinating bioactivities [17] . However, there are only a few studies related to the chemical composition of the Peltophorum species. A preliminary examination showed that the methanol extract and fractions of leaves of P. pterocarpum displayed significant superoxide anion and elastase inhibition at 10 µg/mL (Table 1) . Therefore, we sought to purify the constituents from the leaf extract and Table 1 . Inhibition of P. pterocarpum leave extract and fractions on superoxide anion generation and elastase release in human neutrophils.
Samples
Inhibition Percentage (%) a
Superoxide Anion Generation Elastase Release
Methanol extract 53.4 ± 4.3 *** 112.3 ± 5.0 *** Chloroform fraction 60.7 ± 5.9 *** 113.6 ± 5.9 *** Water fraction 49.4 ± 0.7 *** 50.8 ± 5.0 *** a Percentage of inhibition (Inh %) at 10 µg/mL concentration. Results are presented as mean ± S.E.M. (n = 3). *** p < 0.001 compared with the control value.
Results and Discussion

Isoaltion and Identification
Air-dried and powdered leaves of P. pterocarpum were refluxed with methanol, and the combined extracts were concentrated in vacuo to produce a brownish syrup. This syrup was suspended into water and partitioned with chloroform to afford a chloroform layer and a water soluble fraction respectively. After isolation using a combination of continuous conventional chromatographic techniques, two new compounds, named peltopterins A (1) and B (2), were isolated and their structures established by nuclear magnetic resonance (NMR) and mass spectrometric analyses. Moreover, fifty-two known compounds, including six sesquiterepnoids: rel-5-(3S,8S-dihydroxy-1R,5S-dimethyl-7-oxa-6-oxobicyclo [ 
[20], (3S,5R,6R,7E,9S)-3,5,6,9-tetrahydroxy-7-megastigmene (6) [21], 2,6,6-trimethyl-4-oxo-2-cyclohexene-1-acetic acid (7) [22] , (3S,5R,6S,9S)-megastigmane-3,9,13-triol (8) [23] ; nine benzenoids, p-hydroxybenzoic acid (9) [24] , isovanillic acid (10) [25] , trans-methyl p-coumarate (11) [24] , trans-ferulic acid (12) [26] , methyl ferulate (13) [27] , benzoic acid (14) [28] , vanillic acid (15) [29] , syringic acid (16) [30] , sodium salicylate (17) [31] ; two coumarins: scopoletin (18) [32] , scopolin (19) [33] ; two lignans: dihydrodehydrodiconiferyl alcohol (20) [34] , [18] ; one alkaloid: 4(1H)-quinolinone (22) [35] ; one diterpene: 3(17)-phytene 1,2-diol (23) [36] ; thirteen steroids: a mixture of β-sitosterol (24) and stigmasterol (25) [37, 38] , a mixture of 6β-hydroxystigmast-4-en-3-one (26) and 6β-hydroxystigmasta-4,22-dien-3-one (27) [39, 40] , a mixture of 7-ketositosterol (28) and 3β-hydroxystigmasta-5,22-dien-7-one (29) [41, 42] , a mixture of stigmast-4-en-3-one (30) and stigmast-4,22-dien-3-one (31) [43, 44] , β-sitosteryl-3-O-β-D-glucoside (32) [45] , ergosterol peroxide (33) [52] , cyclotirucanenone (40) [53] , cycloart-25-ene-3β,24-diol (41) [54] , cycloeucalenol (42) [55] ; and twelve flavonoids: (44) [57] , kaempferol 3-O-β-D-glucoside (45) [58] , kaempferol 3-rutinoside (46) [59] , quercetin 3-O-β-D-glucoside (47) [57] , quercetin 3-O-α-L-arabinofuranoside (48) [60], kaempferol , and H-9/H-5 suggested the presence of the partial structures -CH 2 CH(OH)CH 2 -, -CH 2 CHCH-, and -CHCH 2 -, respectively. The 2 J-and 3 J-correlations from H-2 to C-4, C-6, C-10, and C-11; from H-3 to C-5; from H-6 to C-5 and C-9; from H-7 to C-1, C-5, and C-8; and from H-9 to C-4, C-5, and C-8, respectively, could be observed in the heteronuclear multiple bond correlation (HMBC) spectrum ( Figure 1 ). According to these spectral analyses and the index of hydrogen deficiency (IHD = 3), it indicated the presence of two rings and a carbonyl group in 1 and these analytical results constructed the planar structure of 1 (Figure 1) . Furthermore, the coupling pattern of full width at half maximum (FWHM) of H-3 (12.3 Hz) revealed its axial orientation. The nuclear overhauser effect spectroscopy (NOESY) showed NOE correlations between H-3 and H-5 but no correlations were observed between H-5 and H-6. These experimental data established the relative stereochemistry configuration of 1 as shown ( Figure 1 ) and assigned the trivial name peltopterin A. characterized by comparison of their physical and spectroscopic data with those published previously.
Structural Determination of 1 and 2
Compound 1 , and H-9/H-5 suggested the presence of the partial structures -CH2CH(OH)CH2-, -CH2CHCH-, and -CHCH2-, respectively. The 2 J-and 3 J-correlations from H-2 to C-4, C-6, C-10, and C-11; from H-3 to C-5; from H-6 to C-5 and C-9; from H-7 to C-1, C-5, and C-8; and from H-9 to C-4, C-5, and C-8, respectively, could be observed in the heteronuclear multiple bond correlation (HMBC) spectrum ( Figure 1 ). According to these spectral analyses and the index of hydrogen deficiency (IHD = 3), it indicated the presence of two rings and a carbonyl group in 1 and these analytical results constructed the planar structure of 1 ( Figure 1 ). Furthermore, the coupling pattern of full width at half maximum (FWHM) of H-3 (12.3 Hz) revealed its axial orientation. The nuclear overhauser effect spectroscopy (NOESY) showed NOE correlations between H-3 and H-5 but no correlations were observed between H-5 and H-6. These experimental data established the relative stereochemistry configuration of 1 as shown ( Figure 1 ) and assigned the trivial name peltopterin A. Peltopterin B (2) was assigned a molecular formula of C13H20O4 from HR-ESI-MS analysis. The ultraviolet (UV) absorption maxima at 232 nm and the IR absorption bands at 3414 and 1677 cm −1 indicated the occurrence of hydroxyl and conjugated carbonyl groups. The 1 H-NMR spectrum of 2 revealed signals for one vinyl proton at δ 5.84 (1H, s, H-7); four methyl singlets at δ 1.15 (3H, CH3-12), 1.37 (3H, CH3-11), 1.42 (3H, CH3-13) and 2.17 (3H, CH3-10); one oxymethine at δ 4.33 (1H, dddd, J = 11.5, 11.5, 4.0, 4.0 Hz, H-3); and two methylene groups at δ 1.36 (1H, m, H-2ax), 1.43 (1H, m, H-4ax), 1.98 (1H, ddd, J = 11.5, 4.0, 2.5 Hz, H-2eq), and 2.29 (1H, ddd, J = 11.5, 4.0, 2.5 Hz, H-4eq). The 13 C-NMR spectrum also displayed two carbonyl signals at δ 198.5 (C-9) and 209.8 (C-8), three methyl carbons at δ 26.5 (C-10), 29.2 (C-11), and 31.1 (C-13), two methylene carbons at δ 49.1 (C-2) and 48.8 (C-4), two methines at δ 63.4 (C-3) and 100.9 (C-7), and four quaternary carbons at δ 36.3 (C-1), 72.5 (C-5), 118.6 (C-6), and 31.8 (C-12), respectively. The 2 J-and 3 J-HMBC correlations from H-2 to C-3, C-6, C-11, and C-12; from H-4 to C-3, and C-6; from H-7 to C-1, C-5, C-6 and C-9; from CH3-10 to C-9; from CH3-11 to C-1; from CH3-12 to C-1 and C-6; and from CH3-13 to C-4 and C-6, respectively, evidenced the Peltopterin B (2) was assigned a molecular formula of C 13 H 20 O 4 from HR-ESI-MS analysis. The ultraviolet (UV) absorption maxima at 232 nm and the IR absorption bands at 3414 and 1677 cm −1 indicated the occurrence of hydroxyl and conjugated carbonyl groups. The 1 H-NMR spectrum of 2 revealed signals for one vinyl proton at δ 5.84 (1H, s, H-7); four methyl singlets at δ 1.15 (3H, CH 3 -12), 1.37 (3H, CH 3 -11), 1.42 (3H, CH 3 -13) and 2.17 (3H, CH 3 -10); one oxymethine at δ 4.33 (1H, dddd, J = 11.5, 11.5, 4.0, 4.0 Hz, H-3); and two methylene groups at δ 1.36 (1H, m, H-2 ax ), 1.43 (1H, m, H-4 ax ), 1.98 (1H, ddd, J = 11.5, 4.0, 2.5 Hz, H-2 eq ), and 2.29 (1H, ddd, J = 11.5, 4.0, 2.5 Hz, H-4 eq ). The 13 C-NMR spectrum also displayed two carbonyl signals at δ 198.5 (C-9) and 209.8 (C-8), three methyl carbons at δ 26.5 (C-10), 29.2 (C-11), and 31.1 (C-13), two methylene carbons at δ 49.1 (C-2) and 48.8 (C-4), two methines at δ 63.4 (C-3) and 100.9 (C-7), and four quaternary carbons at δ 36.3 (C-1), 72.5 (C-5), 118.6 (C-6), and 31.8 (C-12), respectively. The 2 J-and 3 J-HMBC correlations from H-2 to C-3, C-6, C-11, and C-12; from H-4 to C-3, and C-6; from H-7 to C-1, C-5, C-6 and C-9; from CH 3 -10 to C-9; from CH 3 -11 to C-1; from CH 3 -12 to C-1 and C-6; and from CH 3 -13 to C-4 and C-6, respectively, evidenced the planar structure of 2 as (3,5-dihydroxy-1,1,5-trimethylcyclohexylidene)butan-8,9-dione (Figure 1 ). The NOE correlation between H-3 and CH 3 -13 (see Supplementary Materials) determined the relative stereochemistry at C-5 ( Figure 1 ) and the structure 2 was characterized accordingly. However, the absolute configurations of the two new compounds remained to be determined. Among the purified flavonoid glycosides, compounds 51 and 52 had been reported without NMR spectral data recorded in MeOH-d 4 [63, 64] . In the present study, these compounds were identified through 1D and 2D NMR spectroscopic analysis and the fully assigned NMR data in MeOH-d 4 were listed in Section 3.
Anti-inflammatory Activity
Among these isolates, numerous compounds were selected to be evaluated for the superoxide anion generation and elastase release inhibition by human neutrophils in response to N-formyl-L-methionyl-phenylalanine/cytochalasin B (fMLP/CB) ( Table 2 ). The results indicated that 43, 44, 47, 48, 51 and 52 show a significant inhibition of superoxide anion generation, with the inhibitory percentages ranged from 42.3 ± 4.3 to 48.5 ± 1.0% at 10 µM. In addition, 40, 43, 47, 48 and 52 presented inhibition of elastase release, with inhibitory percentages that ranged from 22.1 ± 5.4 to 32.3 ± 6.8% at 10 µM. Inflammation is a defense mechanism response to bacteria, virus, wound or other various environmental factors resulting in injury. It is also a first response of the immune system to infection and stimulation. In response to diverse stimuli, activated neutrophils secrete a series of cytotoxins, such as superoxide anion and elastase [67] . Therefore, inhibition of superoxide anion production and elastase release in infected tissues and organs could directly modulate neutrophil pro-inflammatory responses. Therefore, the crude extract and purified constituents of P. pterocarpum have potential to be developed as new anti-inflammatory lead drugs or health food ingredients. In comparison, 39 and 41 enhanced the elastase release in CB-priming human neutrophils with values of 73.0 ± 9.8 and 86.8 ± 3.0 % at 10 µM. It had been reported that an increasing elastase release effect promoted the immune response [68, 69] . These results are interesting for the further studies related to the bioactivity and mechanism.
Materials and Methods
General
All the chemicals, unless specifically indicated otherwise, were bought from Merck KGaA (Darmstadt, Germany). The melting points, optical rotations, UV and IR spectra were recorded on an MP-S3 micromelting point apparatus (Yanagimoto, Kyoto, Japan), a P-2000 digital polarimeter (Jasco, Tokyo, Japan), a U-0080D diode array spectrophotometer (Hitachi, Tokyo, Japan), and a FT-IR Spectrum RX1 spectrophotometer (PerkinElmer, Waltham, MA, USA), respectively. The ESI-MS and HR-ESI-MS spectra were obtained on a Bruker Daltonics APEX II 30e spectrometer (Bruker, Billerica, MA, USA). 1 H-, 13 C-, and all 2D NMR (COSY, NOESY, HMQC, and HMBC) spectra were recorded on Bruker AV-500 and Avance III-400 NMR spectrometers (Bruker, Billerica, MA, USA) with tetramethylsilane as the internal standard using deuterated solvents purchased from Sigma-Aldrich (St. Louis, MO, USA). Chemical shifts are reported in parts per million (ppm, δ). Column chromatography and thin layer chromatography (TLC) were conducted on silica gels (Kieselgel 60, 70-230 mesh and 230-400 mesh) and precoated Kieselgel 60 F 254 plates (Merck KGaA), and the compounds were detected by UV light or 10% (v/v) H 2 SO 4 /EtOH reagent.
Plant Materials
The leaves of P. pterocarpum were collected in Vietnam (August 2009) and the plant material was authenticated by Assoc. Prof. Dr. Tran Huy Thai, Institute of Ecology and Biological Resources, Vietnamese Academy of Science and Technology.
Extraction and Isolation
The leaves of P. pterocarpum (dried weight 10.0 kg) were powdered, refluxed with methanol and the combined extracts then concentrated in vacuo to give a brownish syrup (1.2 kg). The crude extract was further separated into chloroform (350 g) and water soluble layers (850 g) by partition between chloroform and water.
The chloroform layer was purified on a silica gel column eluted with n-hexane and a step gradient of ethyl acetate (300:1 to 1:1) to afford nine fractions as monitored by TLC. Fraction 4 was column chromatographed on silica gel with a step gradient mixture of n-hexane and ethyl acetate (100:1 to 1:1) to afford 13 subfractions. Subfraction 4.2 was further purified by preparative TLC eluted with a n-hexane and ethyl acetate solvent mixture (100:1) to yield 38 (0.8 mg) and 40 (4.2 mg). Subfraction 4.5 was further resolved on a silica gel column eluted with a step gradient mixture of n-hexane and acetone (100:1 to 1:1) to produce eight minor fractions (4.5.1-4.5.8). Minor fraction 4.5.2 was purified with pTLC using n-hexane and ethyl acetate (50:1) to yield 37 (7.8 mg). Minor fraction 4.5.4 was isolated with silica gel column chromatography with a mixture of benzene and acetone (300:1) and further recrystallization of the resulting fractions afforded 23 (5.5 mg), a mixture of 26 and 27 (6.5 mg), a mixture of 30 and 31 (4.4 mg), 39 (2.7 mg), and 42 (5.6 mg), respectively. Minor fraction 4.5.7 was performed pTLC purification with a mixture of benzene and acetone (50:1) and produced 41 (4.5 mg). Subfraction 4.6 was isolated by silica gel column chromatography eluted with a mixture of benzene and acetone (300:1) and further recrystallization of the minor fractions produced a mixture of 24 and 25 (15.1 mg), a mixture of 28 and 29 (3.2 mg), and 34 (1.5 mg). Subfraction 4.7 was separated by silica gel column chromatography eluted with a chloroform and acetone solvent mixture (300:1) to yield 12 (2.8 mg) and 35 (1.5 mg). Fraction 5 was further separated by repeated column chromatography over silica gel eluted with n-hexane and a step gradient of acetone (200:1 to 1:1) followed by purification of the resulting subfractions by recrystallization to afford 1 (2.2 mg), 2 (1.6 mg), 5 (2.7 mg), 11 (2.2 mg), 18  (2.2 mg), and 33 (0.8 mg) . Fraction 6 was subjected to silica gel column chromatography eluted with chloroform and a step gradient of methanol (200:1 to 1:1) to produce 13 subfractions. Subfraction 6.6 was further silica gel column chromatographed with a mixture of n-hexane and acetone (20:1) to yield 4 (9.0 mg), 7 (4.3 mg) and 20 (7.8 mg). Fraction 7 was resolved on silica gel column eluted with a step gradient mixture of chloroform and methanol (200:1 to 1:1) to give 17 subfractions. Subfraction 7.10 was further separated by silica column chromatography with a mixture of chloroform and acetone (20:1) to result in 10 (1.5 mg). Subfraction 7.11 was isolated by pTLC with a mixture of chloroform and acetone (20:1) to yield 9 (3.1 mg).
The water soluble layer was applied to a reverse-phase Diaion HP-20 column and eluted with a step gradient of water and methanol (10:0, 7:3, 5:5, 3:7, 0:10) to afford nine fractions. Fraction 4 was further purified with Diaion HP-20 column chromatography eluted with water and a step gradient of methanol (10:0 to 0:10) to afford eight subfractions. Subfraction 4.2 was separated by Diaion HP-20 gel column chromatography as previously described to obtain nine minor fractions. The first minor fraction 4.2.1 was further purified by silica gel column chromatography with a mixture of chloroform and methanol (100:1) to produce 6 (2.3 mg) and 14 (4.5 mg). Minor fraction 4.2.4 was further isolated by repeated column chromatography over silica gel eluted with a step gradient mixture of ethyl acetate and methanol (100:1 to 1:1) to result in 3 (4.0 mg), 16 (2.1 mg), 19 (8.2 mg), and 22 (4.8 mg). Minor fraction 4.2.6 was applied to pTLC with a mixture of ethyl acetate, methanol and water (30:1:0.1) to give 54 (7.2 mg). Fraction 5 was resolved on Diaion HP-20 gel column eluted with water and a step gradient of methanol (10:0 to 0:10) to produce eight subfractions. Subfraction 5.4 was further purified by silica gel column chromatography with a mixture of chloroform and methanol (50:1) to yield six minor fractions. Minor fraction 5.4.1 was subjected to pTLC purification with a mixture of chloroform and methanol (100:1) to obtain 15 (9.1 mg). Minor fraction 5.4.2 was further separated by silica gel column chromatography with a mixture of chloroform, methanol and water (10:1:0.1) to result in 50 (14.1 mg), 51 (2.2 mg), and 52 (4.9 mg). Subfraction 5.5 was separated by repeated column chromatography over silica gel eluted with a step gradient mixture of ethyl acetate and methanol (300:1 to 1:1) followed by recrystallization of the resulting minor fractions to yield 8 (7.4 mg), 17 (1.4 mg), 47 (1.9 mg), and 53 (22.4 mg). Fraction 6 was column chromatographed with Diaion HP-20 gel to give 11 subfractions. Subfraction 6.6 was purified by silica gel column chromatography eluted with a step gradient mixture of chloroform, methanol and water (100:1:0.1 to 1:1:0.1) to produce five minor fractions. Minor fraction 6.6.1 was purified by pTLC with a mixture of chloroform, methanol and water (8:1:0.1) to obtain 44 (2.2 g) and 48 (17.3 mg). Subfraction 6.6.2 was purified by repeated column chromatography over silica gel eluted with a step gradient mixture of ethyl acetate, methanol and water (300:1:0.1 to 1:1:0.1) to yield 36 (3.8 mg), 45 (1.5 mg), 46 (12.6 mg), and 49 (2.8 mg). Subfraction 6.7 was further isolated by silica gel column chromatography eluted with a mixture of chloroform, methanol and water (50:1:0.1) to give six minor fractions. The minor fractions 6.7.4 and 6.7.6 were purified by pTLC with a mixture of chloroform, methanol and water (5:1:0.1) to afford 21 (1.6 mg), 43 (6.3 mg); and 13 (4.2 mg), respectively. Fraction 9 was resolved repeatedly on silica gel column chromatography eluted with a step gradient mixture of ethyl acetate and methanol (300:1 to 1:1) followed by recrystallization of the resulting fractions to obtain 32 (1.5 mg). 1H, m, H-4 
Anti-Inflammatory Bioactivity Examination
The human neutrophils study (No. 1612200032) was approved by the Chang Gung Memorial Hospital Institutional Review Board (Taoyuan, Taiwan) and was conducted according to the Declaration of Helsinki (2013). The examination for the superoxide anion and elastase release inhibition was based on the superoxide dismutase (SOD)-inhibitable reduction of ferricytochrome c and degranulation of azurophilic granules as reported [67] . The experimental details were attached in the file of Supplementary Materials.
